Skip navigation

 

 

 

 

 

 

Get the full picture with

Molecular-level
Insights

CEoT Lunch Symposium
Sponsored by Natera

Saturday, Feb. 27
1:30 – 2:45pm (EST)
Theater 2

Molecular-level Insights in Kidney Transplant Care: Prospera Deep Dive

This session explores the new applications of cell-free and genomic DNA in renal transplant care management, including new data on over 1,300+ patients and in anti-rejection therapy surveillance . Transplant physicians will share their experiences incorporating Prospera into their routine care protocols.

Objectives:

  1. Hear how your transplant colleagues are incorporating Prospera into their routine care protocols
  2. Preview early data on the use of donor-derived cell-free DNA in over 1,300+ kidney recipients
  3. Learn why background cfDNA impacts your protocol for assessing immunosuppression therapy

This is not an o­fficial function of the CEoT Meeting and is not endorsed by AST.

RSVP to hear the latest